Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Simon Christopher Robson, Ph.D., M.B.Ch.B.

Co-Author

This page shows the publications co-authored by Simon Robson and Maria Serena Longhi.
Connection Strength

7.702
  1. Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut. Biochem Pharmacol. 2021 05; 187:114417.
    View in: PubMed
    Score: 0.940
  2. Purinergic signaling during intestinal inflammation. J Mol Med (Berl). 2017 Sep; 95(9):915-925.
    View in: PubMed
    Score: 0.730
  3. Bilirubin suppresses Th17 immunity in colitis by upregulating CD39. JCI Insight. 2017 May 04; 2(9).
    View in: PubMed
    Score: 0.727
  4. Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease. PLoS One. 2014; 9(2):e87956.
    View in: PubMed
    Score: 0.581
  5. NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine. Nat Commun. 2015 Nov 09; 6:8819.
    View in: PubMed
    Score: 0.328
  6. Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19. iScience. 2021 Oct 22; 24(10):103205.
    View in: PubMed
    Score: 0.247
  7. Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver. Front Cell Dev Biol. 2020; 8:621760.
    View in: PubMed
    Score: 0.235
  8. Endogenous antisense RNA curbs CD39 expression in Crohn's disease. Nat Commun. 2020 11 18; 11(1):5894.
    View in: PubMed
    Score: 0.232
  9. Control of Gut Inflammation by Modulation of Purinergic Signaling. Front Immunol. 2020; 11:1882.
    View in: PubMed
    Score: 0.230
  10. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis. J Hepatol. 2021 01; 74(1):48-57.
    View in: PubMed
    Score: 0.227
  11. Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 09; 14(6):818-830.
    View in: PubMed
    Score: 0.227
  12. Author Correction: NADH oxidase-dependent CD39 expression by CD8+ T cells modulates interferon gamma responses via generation of adenosine. Nat Commun. 2020 06 10; 11(1):3036.
    View in: PubMed
    Score: 0.225
  13. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis. Purinergic Signal. 2019 09; 15(3):375-385.
    View in: PubMed
    Score: 0.211
  14. Ectonucleotidases in Intestinal and Hepatic Inflammation. Front Immunol. 2019; 10:507.
    View in: PubMed
    Score: 0.207
  15. Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity. Int J Mol Sci. 2019 Jan 27; 20(3).
    View in: PubMed
    Score: 0.205
  16. HIF-1a-induced xenobiotic transporters promote Th17 responses in Crohn's disease. J Autoimmun. 2018 11; 94:122-133.
    View in: PubMed
    Score: 0.198
  17. CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease. J Autoimmun. 2016 08; 72:102-12.
    View in: PubMed
    Score: 0.170
  18. Reply: To PMID 23787765. Hepatology. 2015 Feb; 61(2):737-8.
    View in: PubMed
    Score: 0.155
  19. CD39 and CD161 modulate Th17 responses in Crohn's disease. J Immunol. 2014 Oct 01; 193(7):3366-77.
    View in: PubMed
    Score: 0.151
  20. Purinergic signaling in liver disease. Dig Dis. 2014; 32(5):516-24.
    View in: PubMed
    Score: 0.150
  21. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology. 2014 Mar; 59(3):1007-15.
    View in: PubMed
    Score: 0.145
  22. Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease. J Clin Transl Hepatol. 2013 Dec; 1(2):79-86.
    View in: PubMed
    Score: 0.144
  23. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J Mol Med (Berl). 2013 Feb; 91(2):165-72.
    View in: PubMed
    Score: 0.135
  24. CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease. Eur J Immunol. 2012 Nov; 42(11):3062-72.
    View in: PubMed
    Score: 0.133
  25. Inhibition of interleukin-17 promotes differentiation of CD25? cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology. 2012 Jun; 142(7):1526-35.e6.
    View in: PubMed
    Score: 0.127
  26. Eosinophils and Purinergic Signaling in Health and Disease. Front Immunol. 2020; 11:1339.
    View in: PubMed
    Score: 0.057
  27. Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells. Inflamm Bowel Dis. 2020 05 12; 26(6):885-897.
    View in: PubMed
    Score: 0.056
  28. P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity. J Cell Sci. 2020 03 06; 133(5).
    View in: PubMed
    Score: 0.055
  29. P2X7 receptor activation increases caveolin-1 expression and macrophage lipid raft formation boosting CD39 activity. J Cell Sci. 2020 Jan 01.
    View in: PubMed
    Score: 0.055
  30. Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. Nature. 2019 Aug; 572(7769):E18.
    View in: PubMed
    Score: 0.053
  31. The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. Nature. 2018 11; 563(7732):564-568.
    View in: PubMed
    Score: 0.050
  32. Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis. Cytokine. 2018 03; 103:38-45.
    View in: PubMed
    Score: 0.048
  33. The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis. Hepatol Commun. 2017 11; 1(9):957-972.
    View in: PubMed
    Score: 0.047
  34. Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease. J Crohns Colitis. 2017 Sep 01; 11(9):1113-1123.
    View in: PubMed
    Score: 0.047
  35. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol. 2017 10; 67(4):716-726.
    View in: PubMed
    Score: 0.046
  36. Novel high-throughput cell-based hybridoma screening methodology using the Celigo Image Cytometer. J Immunol Methods. 2017 08; 447:23-30.
    View in: PubMed
    Score: 0.045
  37. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev. 2017 03; 276(1):121-144.
    View in: PubMed
    Score: 0.045
  38. Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis. 2014 May; 20(5):856-60.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.